Pfizer (NYSE:PFE) Rating Increased to Buy at Vetr

Cornelia Mascio
Dicembre 11, 2017

Northeast Financial Consultants Inc sold 65,499 shares as Pfizer Inc (PFE)'s stock declined 3.45%. Hartford Financial Management Inc. now owns 8,538 shares of the biopharmaceutical company's stock valued at $286,000 after purchasing an additional 835 shares during the last quarter. Northcoast Asset Management Llc acquired 3,646 shares as Everest Re Group Ltd (RE)'s stock rose 3.75%. About 14.90M shares traded. The TJX Companies, Inc. AMREP Corporation (AXR) has risen 41.57% since December 9, 2016 and is uptrending.

Argi Investment Services Llc increased Pfizer Inc Com (PFE) stake by 80.52% reported in 2017Q2 SEC filing. HL Financial Services LLC increased its holdings in shares of Pfizer by 1.1% in the second quarter. The institutional investor held 11,741 shares of the health care company at the end of 2017Q2, valued at $394,000, down from 151,232 at the end of the previous reported quarter. Pfizer Inc. now has $213.04 billion valuation. The stock increased 0.49% or $0.1731 during the last trading session, reaching $35.6731. About 14.90M shares traded.

Pfizer (NYSE:PFE) last issued its quarterly earnings data on Tuesday, October 31st. It has underperformed by 19.46% the S&P500. (NYSE:PFE) has "Outperform" rating given on Monday, May 9 by Credit Suisse. Therefore 89% are positive. Visteon had 44 analyst reports since August 28, 2015 according to SRatingsIntel. Jefferies Group set a $39.00 target price on Pfizer and gave the company a "neutral" rating in a research report on Thursday, November 16th. The company was upgraded on Thursday, September 7 by Northcoast. Institutional investors own 69.89% of the company's stock. (NYSE:PFE) earned "Equal-Weight" rating by Barclays Capital on Tuesday, December 1. The firm has "Neutral" rating given on Wednesday, November 25 by Suntrust Robinson.

Among 8 analysts covering Everest Re Group Ltd (NYSE:RE), 2 have Buy rating, 1 Sell and 5 Hold. As per Friday, November 10, the company rating was maintained by Citigroup. The rating was maintained by Jefferies with "Hold" on Monday, October 16. The firm has "Outperform" rating by RBC Capital Markets given on Friday, November 6. (NYSE:PFE) news were published by: which released: "Pfizer breast cancer drug superior to chemotherapy in late stage study" on December 08, 2017, also with their article: "Pfizer Inc. Being Sucked Into the Retail Apocalypse?" published on December 05, 2017, published: "TJX Companies Inc Stock Is Cheap and for Good Reason" on November 21, 2017. (NYSE:PFE). Obermeyer Wood Counsel Lllp owns 12,137 shares for 0.04% of their portfolio.

Pfizer earned a media sentiment score of 0.16 on Accern's scale. Its down 0.23, from 1.2 in 2017Q1. It improved, as 64 investors sold TJX shares while 367 reduced holdings. Sphera Funds Management LTD. acquired a new stake in shares of Pfizer in the first quarter valued at approximately $13,342,000. (NYSE:PFE). Alliancebernstein Limited Partnership holds 24.59M shares. Huntington Bankshares stated it has 2 shares or 0% of all its holdings. Following the completion of the sale, the insider now owns 117,432 shares of the company's stock, valued at $4,145,349.60. (NYSE:PFE). Ipswich Investment Communication reported 0.55% of its portfolio in Pfizer Inc. Great West Life Assurance Can invested 0% in Visteon Corporation (NYSE:VC). Broderick Brian C holds 19,383 shares or 0.24% of its portfolio. The biopharmaceutical company reported $0.67 earnings per share for the quarter, topping analysts' consensus estimates of $0.65 by $0.02. Fiduciary Tru has invested 2.77% of its portfolio in The TJX Companies, Inc. Barr E S & accumulated 14,218 shares. Ohio-based James has invested 0.8% in Pfizer Inc. It also reduced its holding in Tronox Ltd (NYSE:TROX) by 609,430 shares in the quarter, leaving it with 142,727 shares, and cut its stake in Fidelity Natl Information Sv (NYSE:FIS). Howe & Rusling Inc reported 2.53% stake. Linscomb & Williams owns 118,173 shares for 0.36% of their portfolio. (NYSE:PFE) for 359,000 shares. 643,078 are held by Jarislowsky Fraser. Moreover, Ascend Capital Ltd Llc has 1.59% invested in Pfizer Inc. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the stock. Therefore 43% are positive.

According to Zacks, analysts expect that Pfizer will report full year earnings of $2.59 per share for the current fiscal year, with EPS estimates ranging from $2.57 to $2.60. Jefferies maintained it with "Hold" rating and $38.0 target in Monday, October 16 report. The company has a consensus rating of "Buy" and an average target price of $38.77. The stock has "Hold" rating by S&P Research on Wednesday, October 28. The firm earned "Overweight" rating on Wednesday, September 20 by Morgan Stanley. (NYSE:PFE) rating on Saturday, September 5. Societe Generale maintained Pfizer Inc. Zacks Investment Research upgraded Pfizer from a "hold" rating to a "buy" rating and set a $40.00 price target on the stock in a research report on Tuesday, October 3rd.

Eagle Capital Management LLC purchased a new stake in shares of Pfizer Inc.

Shares of Pfizer Inc.

More notable recent Pfizer Inc. (NYSE:PFE). Northstar Inv Advsrs Ltd Com reported 17,186 shares. Intersect Cap Lc invested 1.23% of its portfolio in Pfizer Inc. (NYSE:PFE) news were published by: which released: "Better Buy: Pfizer Inc. vs. Johnson & Johnson" on December 01, 2017, also with their article: "Townsfolk near Viagra factory talk of 'love fumes, ' but Pfizer says that's a ..." published on December 10, 2017, published: "Viagra goes generic: Pfizer to launch own little white pill" on December 06, 2017.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE